Navigation Links
ViroPharma Incorporated Reports Third Quarter 2008 Financial Results
Date:10/29/2008

br /> For the year 2008, ViroPharma expects the following

-- Net Vancocin sales are expected to be $235 to $245 million;

-- Research and development (R&D) and selling, general and administrative

(SG&A) expenses, excluding the impact of SFAS 123R, are expected to be

$115 to $125 million.

-- The SFAS 123R impact to the above expenses will be approximately 9

million. Including the impact of SFAS 123R, the research and

development (R&D) and sales, general and administrative (SG&A) expenses

are expected to be between $124 and $134 million.

Non-GAAP Disclosures

This press release includes non-GAAP financial information as the Company's projected research and development and marketing, general and administrative expenses has been presented excluding the effect of stock option expense resulting from the application of SFAS 123R. The Company believes that presenting its research and development (R&D) expense and sales, general and administrative (SG&A) expense in this release both with and without the impact of share-based compensation will allow investors to better understand the Company's financial results and how such results compare with the Company's prior results and current guidance.

Conference Call and Webcast

ViroPharma is hosting a live teleconference and webcast with senior management to discuss the financial announcement, guidance, and other business results on October 29, 2008 at 9:00 a.m. Eastern Time. To participate in the conference call, please dial 877-366-0713 (domestic) and 302-607-2000 (international). After placing the call, please tell the operator you wish to join the ViroPharma investor conference call.

Alternatively, the live webcast of the conference call can be accessed via ViroPharma's website at http://www.viropharma.com. Windows Media or Real Player will be needed to access the webcast. An a
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. ViroPharma to Release 2008 Second Quarter Financial Results on July 30, 2008
2. ViroPharma Incorporated Reports First Quarter 2008 Financial Results
3. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results
4. Vincent J. Milano to Succeed Michel de Rosen as President and Chief Executive Officer of ViroPharma
5. ViroPharma Provides Update on Vancocin(R)
6. ViroPharma Augments Senior Management
7. ViroPharma to Present at the 26th Annual JP Morgan Healthcare Conference
8. ViroPharma Receives European Orphan Drug Designation for CAMVIA(TM)
9. ViroPharma Incorporated Reports Third Quarter and Nine-Month 2007 Financial Results
10. ViroPharma to Present at the UBS Global Life Sciences Conference
11. ViroPharma to Present at the Maxim Group First Annual Growth Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... the first genetic variant specifically associated with the ... around 10-15 per cent of all breast cancer ... breast cancer sub-type, called invasive lobular carcinoma, gives ... this particular kind of breast cancer, which can ... today (Thursday) in the journal PloS Genetics ...
(Date:4/17/2014)... the most popular vaccine brands for children may not ... overlooking some cost factors when choosing vaccines, driving the ... according to a new study by University of Illinois ... be driven by numerous factors," says Sheldon H. Jacobson, ... computer science and of mathematics at the U. of ...
(Date:4/17/2014)... Experimental Biology and Medicine a multidisciplinary research ... Kenis in the Institute of Genomic Biology (IGB) ... Urbana-Champaign describe their recent work on subcellular redox ... cell functions including energy metabolism, signaling, and transcriptional ... normal cellular behavior, redox status has been recognized ...
(Date:4/17/2014)... AURORA, Colo. (April 17, 2014) Two recent ... Medicine researcher and colleagues may help scientists develop ... virus, Yellow fever, Japanese encephalitis and other disease-causing ... of biochemistry and molecular genetics at the School ... the Howard Hughes Medical Institute, and colleagues recently ...
(Date:4/17/2014)... Jon McCullers, MD, was recently invited to submit ... Nature Reviews Microbiology , one of the world,s ... infectious disease specialist, and chair of the Department ... Science Center, analyzed the epidemiology and microbiology of ... as well as more recent 2009 novel H1N1 ...
Breaking Medicine News(10 mins):Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Study recalculates costs of combination vaccines 2Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:CU researchers discover target for treating dengue fever 2
... Alan Mozes HealthDay Reporter , THURSDAY, June 16 ... habits of America,s teens, new data from the U.S. Centers ... Not only are high school kids guzzling far too ... CDC research team found. In fact, just one in ...
... A team of social scientists and medical and nursing ... has pinpointed how a programme, which ran in more ... reduced the rates of potentially deadly central line bloodstream ... patient safety programmes. Funded in part by the ...
... MD Diabetes leaders today are responding to the ... (FDA) yesterday that the use of the diabetes medication ... associated with an increased risk of bladder cancer. According ... will be added to the Warnings and Precautions section ...
... quantify causes of death across a population has evolved ... such as heart attack and cancer, the role of ... quantified in the 1990s. More recent research has ... to U.S. mortality. In the first comprehensive analysis of ...
... at Oregon State University has confirmed that an electronic ... to an ambitious goal in the future of medicine ... networks would offer continuous, real-time health diagnosis, experts say, ... and cut health care costs. Some remote health ...
... THURSDAY, June 16 (HealthDay News) -- The quit-smoking drug ... of heart problems in people with cardiovascular disease, the ... In a study of 700 smokers with cardiovascular disease ... researchers saw a small but "statistically significant" greater risk ...
Cached Medicine News:Health News:High School Kids Get Too Many Sugary Drinks, Too Little Exercise: CDC 2Health News:High School Kids Get Too Many Sugary Drinks, Too Little Exercise: CDC 3Health News:International team works out secrets of one of world's most successful patient safety programs 2Health News:International team works out secrets of one of world's most successful patient safety programs 3Health News:Medical societies respond to the FDA's safety announcement on the use of Actos 2Health News:How many US deaths are caused by poverty, low levels of education and other social factors? 2Health News:'Ultrawideband' could be future of medical monitoring 2Health News:Smoking-Cessation Drug Chantix Linked to Heart Problems 2
(Date:1/15/2014)... plc (LSE: SHP, NASDAQ: SHPG ) announces that it ... the announced tender offer for all of the outstanding shares of ... the waiver, the transaction is no longer conditional on OFT approval, ... 2014 following the currently scheduled expiration time, subject to the satisfaction ...
(Date:1/15/2014)... an unprecedented effort to curb the spread of "superbugs" such as ... an advanced and portable UV germicidal lamp manufactured by MRSA-UV is ... In order to prevent EMS paramedics and transport patients ... Palm Beach Fire Rescue is the first in the ...
(Date:1/15/2014)... Jan. 15, 2014 The Cadence Fitness & Health ... by the Medical Fitness Association, a non-profit organization assisting ... full potential. The Cadence Fitness & Health Center is ... and second in the Chicagoland area. "The ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Superbugs No Longer Ride In Rescue Vehicles 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
... ANGN ) today reported financial results for its ... Fourth Quarter Highlights: , Revenues ... sequentially up 22% from the third quarter; , Service ... last year,s fourth quarter; , GPO (group purchasing organization) ...
... BEDFORD, Mass., Dec. 15, 2011  Hologic, Inc. (Hologic or ... leading developer, manufacturer and supplier of premium diagnostic ... to serving the healthcare needs of women, announced ... (FDA) has approved its Cervista HTA (high throughput ...
Cached Medicine Technology:Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 2Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 3Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 4Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 5Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 6Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 7Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 8Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 9Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 10Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 11Angeion Corporation Reports Fourth Quarter and Fiscal Year 2011 Operating Results 12FDA Approves Hologic's Cervista High Throughput Automation System for Cervical Cancer Screening 2FDA Approves Hologic's Cervista High Throughput Automation System for Cervical Cancer Screening 3FDA Approves Hologic's Cervista High Throughput Automation System for Cervical Cancer Screening 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: